| Literature DB >> 31424518 |
K Gharib-Naseri1, S K Kheravii1, C Keerqin1, N Morgan1, R A Swick1, M Choct1, S-B Wu1.
Abstract
Subclinical necrotic enteritis (NE) is primarily caused by the gram-positive bacterium, Clostridium perfringens (Cp). The trend towards removal of in-feed antimicrobials and subsequent increased emergence of infection in poultry has resulted in a wide interest in better understanding of the mechanism behind this disease. The virulence of NE, to a large extent, depends on the virulence of Cp strains. Thus, this study was to assess how 2 different strains of Cp affect performance and gut characteristics of broiler chickens. Ross 308 male broilers (n = 468) were assigned to a 2 × 3 factorial arrangement of treatments with antibiotics (Salinomycin at 72 ppm and zinc bacitracin at 50 ppm -, or +) and challenge (non-challenge, Cp EHE-NE18, or Cp WER-NE36). Oral administration of Eimeria oocysts (day 9) followed by inoculation with 1 mL 108 CFU Cp strains (day 14 and 15) were used to induce NE. Broiler performance was analyzed at day 10, 24, and 35. On day 16, intestinal lesion score and intestinal pH were evaluated and samples of cecal content were analyzed for bacterial counts and short-chain fatty acid concentrations (SCFA). Birds in both challenged groups showed higher feed conversion ratio (FCR), lower weight gain (P < 0.001), increased lesion scores in the jejunum (P < 0.01), and reduced pH in the ileum and cecum (P < 0.01), compared to the non-challenged birds. They also showed decreased numbers of Bacillus spp. (P < 0.001), and Ruminococcus spp. (P < 0.01) in the cecal content. On day 35, the NE36 challenged birds had a lower weight gain (P < 0.001) and higher FCR (P < 0.001) compared to the NE18 challenged birds. Interestingly, cecal Lactobacillus and lactate were increased by the NE challenge (P < 0.001), and to a greater extent in birds challenged with NE36 compared to the NE18 strain (P < 0.001). This study suggests that Cp strains varying in virulence produce different levels of disease in broiler chickens through modulating the gut environment, intestinal microbiota, and SCFA profile to different extents.Entities:
Keywords: zzm321990 Clostridium perfringenszzm321990 ; Necrotic enteritis; chicken; microflora; virulence
Mesh:
Year: 2019 PMID: 31424518 PMCID: PMC8913766 DOI: 10.3382/ps/pez480
Source DB: PubMed Journal: Poult Sci ISSN: 0032-5791 Impact factor: 3.352
Composition and nutrient content of feed.
| Ingredient, % | Starter | Grower | Finisher |
|---|---|---|---|
| Wheat | 30.0 | 44.7 | 34.8 |
| Sorghum | 31.0 | 20.0 | 30.0 |
| Soybean meal | 27.1 | 19.1 | 19.0 |
| Canola meal solvent | 2.00 | 5.00 | 4.5 |
| Meat and bone meal | 4.60 | 5.00 | 5.00 |
| Canola oil | 2.44 | 3.90 | 4.80 |
| Limestone | 0.67 | 0.58 | 0.52 |
| Dical Phos 18P/21Ca | 0.65 | 0.43 | 0.34 |
| Salt | 0.11 | 0.12 | 0.13 |
| Na bicarb | 0.16 | 0.13 | 0.12 |
| UNE VM | 0.09 | 0.09 | 0.09 |
| UNE TM | 0.10 | 0.10 | 0.10 |
| Choline Cl 70% | 0.04 | 0.04 | 0.02 |
| L-lysine HCl 78.4 | 0.41 | 0.35 | 0.32 |
| DL-methionine | 0.31 | 0.24 | 0.25 |
| L-threonine | 0.19 | 0.15 | 0.15 |
| Calculated nutrients | |||
| ME kcal/kg | 3,025 | 3,150 | 3,200 |
| Crude protein % | 23.0 | 22.5 | 21.4 |
| Isoleucine % | 0.98 | 0.87 | 0.87 |
| Digestible Arg % | 1.31 | 1.16 | 1.15 |
| Digestible Lys % | 1.27 | 1.21 | 1.06 |
| Digestible Met % | 0.60 | 0.61 | 0.54 |
| Digestible Thr % | 0.83 | 0.73 | 0.72 |
| Linoleic 18:2% | 1.87 | 2.00 | 1.95 |
Vitamin concentrate (DSM Nutritional Products, Wagga Wagga, NSW, Australia) supplied per kilogram of diet: retinol, 12,000 IU; cholecalciferol, 5,000 IU; tocopheryl acetate, 75 mg, menadione, 3 mg; thiamine, 3 mg; riboflavin, 8 mg; niacin, 55 mg; pantothenate, 13 mg; pyridoxine, 5 mg; folate, 2 mg; cyanocobalamin, 16 μg; biotin, 200 μg; cereal-based carrier, 149 mg; mineral oil, 2.5 mg.
Trace mineral concentrate supplied per kilogram of diet: Cu (sulfate), 16 mg; Fe (sulfate), 40 mg; I (iodide), 1.25 mg; Se (selenate), 0.3 mg; Mn (sulfate and oxide), 120 mg; Zn (sulfate and oxide), 100 mg; cereal-based carrier, 128 mg; mineral oil, 3.75 mg.
Primers used for the qPCR analysis of different bacteria groups.
| Target group | Primer/probe sequence | Amplicon length (bp) | Annealing temp. (C°) | Reference |
|---|---|---|---|---|
| F-GCA ACG AGC GCA ACC CTT GA | 92 | 63 | (Zhang et al., | |
| R-TCA TCC CCA CCT TCC CC GGT | ||||
| F-GAG AGG AAG GTC CCC CAC | 108 | 63 | (Layton et al., | |
| R-CGC TAC TTG GCT GGT TCA G | ||||
| F-GCG TCC GCT GTG GGC | 106 | 63 | (Requena et al., | |
| R-CTT CTC CGG CAT GGT GTT G | ||||
| F- GCA TAA CGT TGA AAG ATG G | 120 | 60 | (Wise and Siragusa, | |
| R- CCT TGG TAG GCC GTT ACC C | ||||
| TaqMan probe: 5′-FAM-TCA TCA TTC AAC CAA AGG AGC AAT CC-TAMRA-3′ | ||||
| F-CAC CGC TAC ACA TGG AG | 186 | 63 | (Wise and Siragusa, | |
| R-AGC AGT AGG GAA TCT TCC A | ||||
| F-GGC GGC YTR CTG GGC TTT | 157 | 63 | (Ramirez-Farias et al., | |
| R-CCA GGT GGA TWA CTT ATT GTG TTA A |
Performance of chickens in response to the challenge with 2 strains of Clostridium perfringens and supplementation of antibiotics during 0 to 35 D of age.
| Performance | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 0 to 10 | 0 to 24 | 0 to 35 | ||||||||
| Challenge | Antibiotics | BW | FI | FCR | BW | FI | FCR | BW | FI | FCR |
| Non-challenge | No | 284 | 284 | 1.010 | 1,366 | 1,705 | 1.247 | 2,529 | 3,363 | 1.330 |
| Yes | 282 | 282 | 1.005 | 1,356 | 1,697 | 1.251 | 2,551 | 3,436 | 1.347 | |
| NE-18 | No | 284 | 285 | 0.998 | 1,103 | 1,431 | 0.998 | 2,258 | 3,216 | 1.424 |
| Yes | 292 | 291 | 1.027 | 1,193 | 1,527 | 1.027 | 2,450 | 3,356 | 1.373 | |
| NE-36 | No | 293 | 293 | 1.023 | 1,052 | 1,479 | 1.023 | 2,157 | 3,173 | 1.475 |
| Yes | 290 | 291 | 1.017 | 1,180 | 1,528 | 1.017 | 2,327 | 3,340 | 1.435 | |
| Main effects | ||||||||||
| Antibiotic | ||||||||||
| No | 288 | 287 | 1.009 | 1,174 | 1,538 | 1.323 | 2,315 | 3,249 | 1.403 | |
| Yes | 287 | 289 | 1.012 | 1,243 | 1,590 | 1.292 | 2,443 | 3,380 | 1.385 | |
| Challenge | ||||||||||
| Non-challenged | 283 | 289 | 1.007 | 1,361 | 1,701 | 1.250 | 2,540 | 3,396 | 1.338 | |
| NE18 | 288 | 291 | 1.002 | 1,148 | 1,479 | 1.308 | 2,354 | 3,289 | 1.398 | |
| NE36 | 290 | 284 | 1.025 | 1,116 | 1,503 | 1.362 | 2,242 | 3,257 | 1.455 | |
| | ||||||||||
| Antibiotic | 0.693 | 0.693 | 0.666 | 0.010 | 0.162 | 0.032 | <0.001 | 0.002 | 0.074 | |
| Challenge | 0.411 | 0.409 | 0.091 | 0.001 | 0.001 | 0.001 | <0.001 | 0.016 | < 0.001 | |
| Antibiotic × challenge | 0.610 | 0.609 | 0.754 | 0.084 | 0.453 | 0.170 | 0.013 | 0.636 | 0.091 | |
Salinomycin (72 ppm) and zinc bacitracin (50 ppm).
Clostridium perfringens strains (108 CFU/mL).
Means sharing the same superscripts are not significantly different from each other at P < 0.05. BW: Body Weight gain (g/bird), FI: Feed intake (g/bird), FCR: Feed conversion ratio.
Figure 1Individual and average intestinal lesion scores of all sampled birds (day 16) challenged with 2 strains of Clostridium perfringens (NE18 and NE36). (A) lesion score in duodenum; (B) lesion score in jejunum; (C) lesion score in ileum; (D) Mortality of birds at day 14 to 16.
Intestinal pH in responses to the challenge with Clostridium perfringens strains NE18 and NE36 and antibiotic supplementation in chickens at day 16.
| pH | ||
|---|---|---|
| Main effects | Cecum | Ileum |
| Antibiotic | ||
| No | 6.40 | 5.81 |
| Yes | 6.44 | 5.86 |
| Challenge | ||
| Non-challenge | 6.55 | 5.97 |
| NE18 | 6.35 | 5.80 |
| NE36 | 6.36 | 5.74 |
| Antibiotic | 0.338 | 0.387 |
| Challenge | 0.001 | 0.004 |
| Antibiotic × challenge | 0.481 | 0.926 |
Salinomycin (72 ppm) and zinc bacitracin (50 ppm).
Clostridium perfringens strains (108 CFU/mL).
Means sharing the same superscripts are not significantly different from each other at P < 0.05.
Figure 2Bacterial levels (Log10 copies of respective bacterial genome) in cecal content of birds in response to challenge with NE18 and NE36 strains of Clostridium perfringens and antibiotic supplementation at day 16. GDC: Genomic DNA copies/g; CNT: No antibiotic supplementation; ANT: Antibitotic supplementation (Salinomycin at 72 ppm and zinc bacitracin at 50 ppm); NON: Non-challenged; NE18: birds challenged with NE18 strain; NE36: birds challenged with NE36 strain.
Figure 3(A) A strong positive correlation between cecal Lactobacillus level and lactate concentration in cecum contents; (B) A negative correlation between cecal Lactobacillus level and cecal pH.
Concentration of short-chain fatty acids (μmol/g) in cecal content in responses to the challenge with Clostridium perfringens strains NE18 and NE36 and antibiotic supplementation in chickens at day 16.
| Cecal SCFA (μmol/g) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Main effect | Acetate | Propionate | Isobutyrate | Butyrate | Isovalerate | Valerate | Lactate | Succinate |
| Antibiotic | ||||||||
| No | 88.7 | 7.14 | 0.96 | 17.2 | 0.36 | 1.90 | 6.29 | 7.07 |
| Yes | 91.3 | 4.86 | 0.80 | 19.5 | 0.23 | 1.88 | 3.26 | 8.07 |
| Challenge | ||||||||
| Non-challenged | 101.0 | 4.55 | 0.60 | 24.6 | 0.15 | 1.24 | 1.35 | 6.43 |
| NE18 | 83.4 | 5.36 | 1.02 | 16.1 | 0.40 | 1.84 | 3.38 | 8.30 |
| NE36 | 85.4 | 8.07 | 1.02 | 14.6 | 0.35 | 2.60 | 10.7 | 8.92 |
| Antibiotic | 0.628 | 0.011 | 0.149 | 0.300 | 0.106 | 0.922 | 0.010 | 0.802 |
| Challenge | 0.021 | 0.005 | 0.002 | 0.002 | 0.027 | 0.001 | 0.001 | 0.368 |
| Antibiotic × challenge | 0.916 | 0.102 | 0.088 | 0.921 | 0.544 | 0.652 | 0.333 | 0.269 |
Salinomycin (72 ppm) and zinc bacitracin (50 ppm).
Clostridium perfringens strains (108 CFU/mL).
Means sharing the same superscripts are not significantly different from each other atP < 0.05.
Pearson correlations between cecal SCFA concentrations or pH and bacterial populations (log10 GDC1).
| Acetate | Lactate | Propionate | Butyrate | Valerate | Succinate | Isovalerate | Isobutyrate | Cecal pH | |
|---|---|---|---|---|---|---|---|---|---|
| 0.058 | −0.015 | −0.270 | 0.481** | −0.420* | 0.046 | −0.479** | −0.495** | 0.321 | |
| −0.187 | 0.008 | 0.211 | −0.214 | 0.068 | −0.078 | 0.257 | 0.174 | 0.097 | |
| 0.196 | −0.537* | −0.381* | 0.305 | −0.447* | −0.173 | −0.424** | −0.651 | 0.300 | |
| −0.486** | 0.392** | 0.427* | −0.567*** | 0.573*** | 0.206 | 0.501** | 0.603** | −0.606*** | |
| −0.568* | 0.806*** | 0.423* | −0.468** | 0.520** | 0.291 | 0.046 | 0.317 | −0.480** | |
| 0.195 | −0.192 | −0.192 | 0.173 | −0.174 | −0.402** | −0.292 | −0.382** | 0.239 |
Stars (*) donate the strength of the significance: P < 0.001***, 0.001 < P < 0.01**, 0.01 < P < 0.05*.
GDC: genomic DNA copy number.